Bandingkan Harga & Kinerja Hexindo Adiperkasa Tbk. (HEXA) vs Millennium Pharmacon International Tbk. (SDPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Hexindo Adiperkasa Tbk. dan Millennium Pharmacon International Tbk.: Hexindo Adiperkasa Tbk. diperdagangkan di Rp4.420 (kapitalisasi pasar 3,66 T, volume 24 jam 165,4 rb), sedangkan Millennium Pharmacon International Tbk. diperdagangkan di Rp181 (kapitalisasi pasar 230,59 M, volume 24 jam 12,1 rb). Perbedaan utamanya: Hexindo Adiperkasa Tbk. jauh lebih besar — sekitar 15,9× kapitalisasi pasar Millennium Pharmacon International Tbk., dan Hexindo Adiperkasa Tbk. lebih aktif diperdagangkan (165,4 rb vs 12,1 rb). Mana yang lebih baik tergantung tujuan investasimu.
| HEXA | SDPC | |
|---|---|---|
Kapitalisasi Pasar | 3,66 T | 230,59 M |
Volume | 165,4 rb | 12,1 rb |
Lot | 1,65 rb | 121 |
Perputaran | 732,19 jt | 2,2 jt |
Harga Rata-rata | 4.426,75 | 181,48 |
Nilai Transaksi | 732,19 jt | 2,2 jt |
Harga Ekuilibrium Indikatif | 4.420 | — |
Volume Ekuilibrium Indikatif | 56 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Hexindo Adiperkasa Tbk.
PT Hexindo Adiperkasa Tbk (the Company) was established on November 28, 1988 based on notarial deed No.37 of Mohamad Ali. The deed of establishment was approved by the Ministry of Justice in its decision letter No. C2-4389.HT.01.01.TH.89 dated May 12, 1989 and was published in Supplement No. 1251 of the State Gazette No.54 dated July7, 1989. Presently, the Company acts as a distributor of certain heavy equipment and related spare parts with the trademark of Hitachi, John Deere and Ammann. The Company’s registration statement for the public offering of its 10 million shares of stocks (with Rp 1000 per value per share) at on offer price of Rp 2,800 per share become affective in accordance with the letter No.S-1958/PM/1994 dated December 5, 1994 issued by the Chairman of the Capital Market Supervisory Agency (BAPEPEAM). The excess of the proceeds over the par value of the shares of stock was recorded as “Capital paid in excess of par value”. The Company’s registration statement for the first limited public offering of 42 million shares to stockholders with pre-emptive rights (with Rp 1,000 per value per share) at an offer price of Rp 1,000 per share became effective in accordance with the letter No.S-1264/PM/1998 dated June 19, 1998 issued by the Chairman of BAPEPAM.
Selengkapnya di halaman HEXA →Tentang Millennium Pharmacon International Tbk.
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Selengkapnya di halaman SDPC →
